Pfizer, PhRMA back SOPA amid online protests

With dozens of websites blocked in protest of new anti-piracy legislation, Pfizer ($PFE) and PhRMA are among the intellectual-property champions that are lobbying for, rather than against, the proposed laws. Pfizer says the measures--one approved by the House, another by the Senate--would help prevent drug counterfeiting. Report